Beta tests have demonstrated success with The Camden Group’s medical group performance monitoring services using the dashboardMD tool that tracks scheduling, productivity, coding, revenue cycle management and clinical quality measures.
“We’re thrilled to be working closely with The Camden Group,” said Jose Valero, president and CEO of dashboardMD. “By combining dashboardMD’s turnkey analytic reporting suite with The Camden Group’s expertise and extensive experience, we can better leverage the practice information to act quickly and more effectively implement executive initiatives with demonstrable results.”
More articles on finance issues:
5 current trends in health system transactions and joint ventures
California becomes first state to cap specialty drug prices
6 projects on CMS’ proposed managed care rule
